Ostroff J, Garland J, Moadel A, Fleshner N, Hay J, Cramer L, Zauber A, Trambert R, O'Sullivan M E, Russo P
Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
J Cancer Educ. 2000 Summer;15(2):86-90. doi: 10.1080/08858190009528663.
Assessment of smoking status and identification of those most likely to continue smoking are important in the management of patients who have bladder cancer, because continued smoking following diagnosis and treatment increases the likelihood of treatment-related complications, recurrence, second primary malignancies, and morbidity and mortality.
Patients (n = 224) receiving follow-up care of previously treated bladder cancers completed a brief written survey assessing their post-diagnosis smoking patterns.
Despite the risks of continued smoking, 69% of the patients who had been active smokers at the time of diagnosis (n = 84) reported smoking at some point following the diagnosis and 45% reported smoking at the time of assessment. Patients diagnosed at earlier stages were more likely to continue smoking. Patients diagnosed at later stages were 2.80 times more likely to be continuous abstainers than those diagnosed sooner (95% CI, 1.08-7.25).
The findings underscore the need to assess smoking status and provide smoking-cessation advice and counseling within routine comprehensive care of bladder cancer patients.
评估吸烟状况以及确定最有可能继续吸烟的人群，对于膀胱癌患者的管理至关重要，因为诊断和治疗后继续吸烟会增加治疗相关并发症、复发、第二原发性恶性肿瘤以及发病和死亡的可能性。
接受过膀胱癌治疗的随访护理的患者（n = 224）完成了一项简短的书面调查，评估他们诊断后的吸烟模式。
尽管继续吸烟存在风险，但69%在诊断时为现吸烟者（n = 84）的患者报告在诊断后的某个时间点仍在吸烟，45%的患者在评估时报告仍在吸烟。早期诊断的患者更有可能继续吸烟。晚期诊断的患者成为持续戒烟者的可能性是早期诊断患者的2.80倍（95%CI，1.08 - 7.25）。
这些发现强调了在膀胱癌患者的常规综合护理中评估吸烟状况并提供戒烟建议和咨询的必要性。
